Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

1626
1
Absci Corp Absci Corporation Reports 129% Revenue Growth in Q3, Net Loss Widens

Via official filing (AI summary) | 11 days ago | 0 comments

1627
1
Roivant Sciences Ltd. Roivant Sciences Reports Revenue Growth, Increased Expenses, and Net Loss in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1628
1
Thoughtworks Holding, Inc. Thoughtworks Reports Decline in Revenue and Net Loss for Q3 and Nine Months of 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1629
1
TScan Therapeutics, Inc. TScan Therapeutics Reports Decline in Collaboration Revenue, Increased Operating Expenses in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1630
1
Dyne Therapeutics, Inc. Dyne Therapeutics Reports Significant Asset Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1631
1
Qualis Innovations, Inc. Qualis Innovations Reports Significant Financial Improvements, Net Loss Narrows in Latest 10-Q Filing

Via official filing (AI summary) | 11 days ago | 0 comments

1632
1
Maiden Holdings, Ltd. Maiden Holdings Reports Significant Net Loss and Revenue Decline in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1633
1
SPRUCE BIOSCIENCES, INC. Spruce Biosciences Reports Financial Results, Implements Cost Reduction Measures, and Explores Additional Financing Options

Via official filing (AI summary) | 11 days ago | 0 comments

1634
1
ASSURED GUARANTY LTD Assured Guaranty Ltd. Reports Mixed Q3 2024 Results, Decline in Revenues and Adjusted Operating Income

Via official filing (AI summary) | 11 days ago | 0 comments

1635
1
Perimeter Solutions, SA Perimeter Solutions Reports 102% Net Sales Growth, Operating Loss in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1636
1
reAlpha Tech Corp. reAlpha Tech Corp. Reports 475% Revenue Growth, Operating Losses in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1637
1
Vincerx Pharma, Inc. Vincerx Pharma Reports Significant Decrease in Cash and Cash Equivalents, Operating Expenses, and Net Loss

Via official filing (AI summary) | 11 days ago | 0 comments

1638
1
ReWalk Robotics Ltd. LifeWard Ltd. Reports 39% Revenue Growth, Narrowing Losses in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1639
1
WERNER ENTERPRISES INC Werner Enterprises Reports Decline in Revenue and Net Income for Q3 and Nine Months of 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1640
1
HERON THERAPEUTICS, INC. /DE/ Heron Therapeutics Reports Improved Revenue and Reduced Losses in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1641
1
NEVRO CORP Nevro Corp. Reports Decline in Revenue and Profitability for Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1642
1
FEMASYS INC Femasys Inc. Reports 127% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1643
1
DZS INC. DZS Inc. Reports 67.8% Revenue Growth, Improved Profitability in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1644
1
UFP TECHNOLOGIES INC UFP Technologies Reports 44% Revenue Growth in Q3 2024, Driven by Medical Market and Strategic Acquisitions

Via official filing (AI summary) | 11 days ago | 0 comments

1645
1
CervoMed Inc. CervoMed Reports Significant Net Loss and Increased Grant Revenue in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1646
1
Mineralys Therapeutics, Inc. Mineralys Therapeutics Reports Increased Cash Reserves, Rising Operating Expenses, and Net Loss in Latest Quarter

Via official filing (AI summary) | 11 days ago | 0 comments

1647
1
GILEAD SCIENCES, INC. Gilead Sciences Reports Mixed Q3 Results with Increased Revenues and Declining Profitability

Via official filing (AI summary) | 11 days ago | 0 comments

1648
1
Assertio Holdings, Inc. Assertio Holdings Reports Decline in Revenues, Improvement in Profitability in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1649
1
SIEBERT FINANCIAL CORP Siebert Financial Reports Strong Revenue Growth and Improved Profitability in Q3 2024

Via official filing (AI summary) | 11 days ago | 0 comments

1650
1
Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals Reports Significant Revenue Growth and Strategic Acquisitions in Latest 10-Q Filing

Via official filing (AI summary) | 11 days ago | 0 comments